title: Modulatory effects of VIP and related peptides from the gastrointestinal tract on cell mediated cytotoxicity against tumour cells in vitro.
abstract: In the present study the effect of vasoactive intestinal peptide (VIP), peptide histidine-methionine (PHM), and secretin on spontaneous cell mediated cytotoxicity of peripheral blood mononuclear cells against tumour target cells was evaluated. VIP stimulated cytotoxicity against CaCo-2 human colon cancer cells, whereas less effect was seen against K-562 erythroleukemia cells. Depletion of CD16+ natural killer cells almost completely abolished cytotoxicity and subsequent VIP incubation did not change residual activity. In contrast to PHM, which hardly influenced cytotoxicity, secretin was found to be more effective especially against K-562 target cells. These observations suggest a modulating role for the neuropeptide VIP in the cellular immune response against tumour cells, especially from the colon, resulting in increased activity of CD16+ natural killer cells. Secretin, seems to be less potent in modulating cellular cytotoxicity. These findings support the concept that gastrointestinal peptides can play a role in the regulation of cellular cytotoxicity against tumor cells.
authors.affiliation: Department of Gastroenterology and Hepatology, University Hospital, Leiden, The Netherlands.
authors.forename: E A
authors.initials: EA
authors.lastname: van Tol
authors.forename: H W
authors.initials: HW
authors.lastname: Verspaget
authors.forename: A S
authors.initials: AS
authors.lastname: Peña
authors.forename: J B
authors.initials: JB
authors.lastname: Jansen
authors.forename: M N
authors.initials: MN
authors.lastname: Aparicio-Pagés
authors.forename: C B
authors.initials: CB
authors.lastname: Lamers
mesh_terms: D003110:Colonic Neoplasms / Q000276:immunology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D004915:Leukemia, Erythroblastic, Acute / Q000473:pathology; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000276:immunology*; D015213:Neuroimmunomodulation; D010451:Peptide PHI / Q000494:pharmacology*; D012633:Secretin / Q000494:pharmacology*; D013268:Stimulation, Chemical; D014407:Tumor Cells, Cultured / Q000276:immunology*; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*
chemical_list: D010451:Peptide PHI; D012633:Secretin; D014660:Vasoactive Intestinal Peptide